{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:35Z","timestamp":1707524975052},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,7]]},"DOI":"10.7759\/cureus.37235","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T08:25:33Z","timestamp":1680855933000},"source":"Crossref","is-referenced-by-count":0,"title":["Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison"],"prefix":"10.7759","author":[{"given":"Zineb","family":"Dahbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhen","family":"Fadila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Vinh-Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino J","year":"2020","unstructured":"Chino J, Annunziata CM, Beriwal S, et al.. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2020, 10:220-34. 10.1016\/j.prro.2020.04.002","journal-title":"Pract Radiat Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2021.11.009","article-title":"Radiotherapy of cervical cancer","volume":"26","author":"Chargari C","year":"2022","unstructured":"Chargari C, Peignaux K, Escande A, et al.. Radiotherapy of cervical cancer. Cancer Radiother. 2022, 26:298-308. 10.1016\/j.canrad.2021.11.009","journal-title":"Cancer Radiother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2018.01.001","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter R","year":"2018","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, et al.. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018, 9:48-60. 10.1016\/j.ctro.2018.01.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"[Delineation of organs at risk and dose constraints]","volume":"20 Suppl","author":"No\u00ebl G","year":"2016","unstructured":"No\u00ebl G, Antoni D, Barillot I, Chauvet B. [Delineation of organs at risk and dose constraints]. Cancer Radiother. 2016, 20 Suppl:S36-60. 10.1016\/j.canrad.2016.07.032","journal-title":"Cancer Radiother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2022.2081790","article-title":"Stereotactic body radiotherapy boost in patients with cervical cancer","volume":"42","author":"Gultekin M","year":"2022","unstructured":"Gultekin M, Yilmaz MT, Yuce Sari S, Yildiz D, Ozyigit G, Yildiz F. Stereotactic body radiotherapy boost in patients with cervical cancer. J Obstet Gynaecol. 2022, 42:3033-40. 10.1080\/01443615.2022.2081790","journal-title":"J Obstet Gynaecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205166","article-title":"Stereotactic body radiotherapy boost with the cyberknife for locally advanced cervical cancer: dosimetric analysis and potential clinical benefits","volume":"14","author":"Gao J","year":"2022","unstructured":"Gao J, Xu B, Lin Y, et al.. Stereotactic body radiotherapy boost with the cyberknife for locally advanced cervical cancer: dosimetric analysis and potential clinical benefits. Cancers (Basel). 2022, 14:10.3390\/cancers14205166","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01877-4","article-title":"Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible","volume":"16","author":"Lee TH","year":"2021","unstructured":"Lee TH, Song C, Kim IA, et al.. Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible. Radiat Oncol. 2021, 16:148. 10.1186\/s13014-021-01877-4","journal-title":"Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2020.05.003","article-title":"[Can stereotactic body radiotherapy replace brachytherapy for locally advanced cervical cancer? French society for radiation oncology statement]","volume":"24","author":"Chargari C","year":"2020","unstructured":"Chargari C, Renard S, Espenel S, et al.. [Can stereotactic body radiotherapy replace brachytherapy for locally advanced cervical cancer? French society for radiation oncology statement]. Cancer Radiother. 2020, 24:706-13. 10.1016\/j.canrad.2020.05.003","journal-title":"Cancer Radiother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10008","article-title":"Stereotactic body radiation therapy boost in patients with cervical cancer ineligible for brachytherapy","volume":"1","author":"Facondo G","year":"2021","unstructured":"Facondo G, Vullo G, DE Sanctis V, et al.. Stereotactic body radiation therapy boost in patients with cervical cancer ineligible for brachytherapy. Cancer Diagn Progn. 2021, 1:53-60. 10.21873\/cdp.10008","journal-title":"Cancer Diagn Progn"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2014.04.005","article-title":"Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: a virtual brachytherapy study","volume":"19","author":"Otahal B","year":"2014","unstructured":"Otahal B, Dolezel M, Cvek J, et al.. Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: a virtual brachytherapy study. Rep Pract Oncol Radiother. 2014, 19:399-404. 10.1016\/j.rpor.2014.04.005","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2018.08.005","article-title":"What is the evidence for the clinical value of SBRT in cancer of the cervix?","volume":"23","author":"Yanez L","year":"2018","unstructured":"Yanez L, Ciudad AM, Mehta MP, Marsiglia H. What is the evidence for the clinical value of SBRT in cancer of the cervix?. Rep Pract Oncol Radiother. 2018, 23:574-9. 10.1016\/j.rpor.2018.08.005","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2013.06.035","article-title":"[Alpha\/beta ratio revisited in the era of hypofractionation]","volume":"17","author":"Hennequin C","year":"2013","unstructured":"Hennequin C, Dubray B. [Alpha\/beta ratio revisited in the era of hypofractionation]. Cancer Radiother. 2013, 17:344-8. 10.1016\/j.canrad.2013.06.035","journal-title":"Cancer Radiother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill BS","year":"2014","unstructured":"Gill BS, Lin JF, Krivak TC, et al.. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. Int J Radiat Oncol Biol Phys. 2014, 90:1083-90. 10.1016\/j.ijrobp.2014.07.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2018.06.002","article-title":"[Recent data in cervical cancer: radiation oncologist's perspective]","volume":"22","author":"Chargari C","year":"2018","unstructured":"Chargari C, Gouy S, Pautier P, Haie-Meder C. [Recent data in cervical cancer: radiation oncologist's perspective]. Cancer Radiother. 2018, 22:502-8. 10.1016\/j.canrad.2018.06.002","journal-title":"Cancer Radiother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.09.002","article-title":"Isodose surface volumes in cervix cancer brachytherapy: change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy","volume":"129","author":"Serban M","year":"2018","unstructured":"Serban M, Kirisits C, P\u00f6tter R, et al.. Isodose surface volumes in cervix cancer brachytherapy: change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy. Radiother Oncol. 2018, 129:567-74. 10.1016\/j.radonc.2018.09.002","journal-title":"Radiother Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S40370","article-title":"Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result","volume":"6","author":"Hsieh CH","year":"2013","unstructured":"Hsieh CH, Tien HJ, Hsiao SM, et al.. Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result. Onco Targets Ther. 2013, 6:59-66. 10.2147\/OTT.S40370","journal-title":"Onco Targets Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/898953","article-title":"Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer","volume":"2013","author":"Kubicek GJ","year":"2013","unstructured":"Kubicek GJ, Xue J, Xu Q, et al.. Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer. Biomed Res Int. 2013, 2013:898953. 10.1155\/2013\/898953","journal-title":"Biomed Res Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00025\/full","article-title":"CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy","volume":"2","author":"Haas JA","year":"2012","unstructured":"Haas JA, Witten MR, Clancey O, Episcopia K, Accordino D, Chalas E. CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy. Front Oncol. 2012, 2:25. 10.3389\/fonc.2012.00025\/full","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2011.12.001","article-title":"Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer","volume":"11","author":"Cengiz M","year":"2012","unstructured":"Cengiz M, Dogan A, Ozyigit G, et al.. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy. 2012, 11:125-9. 10.1016\/j.brachy.2011.12.001","journal-title":"Brachytherapy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/122078-brachytherapy-versus-stereotactic-body-radiotherapy-for-cervical-cancer-boost-a-dosimetric-comparison","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:43Z","timestamp":1707508663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/122078-brachytherapy-versus-stereotactic-body-radiotherapy-for-cervical-cancer-boost-a-dosimetric-comparison"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.37235","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,7]]}}}